A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Clinical trial NCT00094367 · COMPLETED
Trial details
- NCT number
- NCT00094367
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2005-10-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.